These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7887827)

  • 1. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
    Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
    Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
    Ashraf S; Tian Y; Cowan D; Entress A; Martin PG; Watterson KG
    Ann Thorac Surg; 1997 Dec; 64(6):1790-4. PubMed ID: 9436574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
    Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a silicone coated hollow fiber oxygenator.
    Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
    ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
    Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
    Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
    Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
    Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization.
    DiSesa VJ; Huval W; Lelcuk S; Jonas R; Maddi R; Lee-Son S; Shemin RJ; Collins JJ; Hechtman HB; Cohn LH
    Ann Thorac Surg; 1984 Nov; 38(5):514-9. PubMed ID: 6388516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood conservation with membrane oxygenators and dipyridamole.
    Teoh KH; Christakis GT; Weisel RD; Madonik MM; Ivanov J; Wong PY; Mee AV; Levitt D; Benak A; Reilly P
    Ann Thorac Surg; 1987 Jul; 44(1):40-7. PubMed ID: 3300583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
    Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
    Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of a heparin-coated oxygenator during cardiopulmonary bypass on postoperative lung oxygenation capacity in pediatric patients with congenital heart anomalies.
    Watanabe H; Miyamura H; Hayashi J; Ohzeki H; Sugawara M; Takahashi Y; Eguchi S
    J Card Surg; 1996; 11(6):396-401. PubMed ID: 9083864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.
    Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U
    Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Carmeda BioActive Surface coating versus Trillium Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
    Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Elmore BA; Gustafson PA; Castagna JM
    Perfusion; 2001 Jul; 16(4):279-83. PubMed ID: 11486846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
    van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.